Arete Wealth Advisors’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-9,636
| Closed | -$765K | – | 404 |
|
|
2025
Q4 | $765K | Sell |
9,636
-866
| -8% | -$68.3K | 0.05% | 334 |
|
|
2025
Q3 | $792K | Buy |
10,502
+92
| +0.9% | +$6.3K | 0.05% | 325 |
|
|
2025
Q2 | $718K | Buy |
10,410
+2,670
| +34% | +$175K | 0.05% | 317 |
|
|
2025
Q1 | $524K | Buy |
7,740
+1,839
| +31% | +$110K | 0.04% | 377 |
|
|
2024
Q4 | $264K | Sell |
5,901
-15,854
| -73% | -$889K | 0.02% | 600 |
|
|
2024
Q3 | $1.37M | Buy |
+21,755
| New | +$1.27M | 0.12% | 171 |
|
|
2024
Q1 | – | Sell |
-24,214
| Closed | -$1.91M | – | 450 |
|
|
2023
Q4 | $1.91M | Buy |
+24,214
| New | +$1.72M | 0.15% | 147 |
|
|
2023
Q3 | – | Sell |
-15,366
| Closed | -$1.06M | – | 542 |
|
|
2023
Q2 | $1.06M | Sell |
15,366
-8,810
| -36% | -$627K | 0.09% | 210 |
|
|
2023
Q1 | $1.8M | Buy |
24,176
+4,352
| +22% | +$365K | 0.15% | 132 |
|
|
2022
Q4 | $1.85B | Sell |
19,824
-1,103
| -5% | -$106K | 0.16% | 116 |
|
|
2022
Q3 | $2M | Buy |
20,927
+5,942
| +40% | +$588K | 0.2% | 104 |
|
|
2022
Q2 | $1.39M | Sell |
14,985
-354
| -2% | -$34.5K | 0.14% | 118 |
|
|
2022
Q1 | $1.55M | Sell |
15,339
-2,373
| -13% | -$249K | 0.13% | 138 |
|
|
2021
Q4 | $1.84M | Buy |
17,712
+1,612
| +10% | +$149K | 0.16% | 124 |
|
|
2021
Q3 | $1.36M | Buy |
16,100
+364
| +2% | +$30.5K | 0.15% | 133 |
|
|
2021
Q2 | $1.19M | Sell |
15,736
-2,206
| -12% | -$181K | 0.17% | 121 |
|
|
2021
Q1 | $1.35M | Sell |
17,942
-736
| -4% | -$53.6K | 0.17% | 126 |
|
|
2020
Q4 | $1.28M | Sell |
18,678
-234
| -1% | -$15.2K | 0.18% | 118 |
|
|
2020
Q3 | $1.09M | Buy |
18,912
+1,180
| +7% | +$73.4K | 0.16% | 140 |
|
|
2020
Q2 | $1.15M | Sell |
17,732
-3,197
| -15% | -$201K | 0.2% | 127 |
|
|
2020
Q1 | $1.24M | Buy |
20,929
+1,349
| +7% | +$90.1K | 0.24% | 97 |
|
|
2019
Q4 | $1.45M | Sell |
19,580
-542
| -3% | -$38.1K | 0.25% | 96 |
|
|
2019
Q3 | $1.27M | Buy |
20,122
+1,285
| +7% | +$76.1K | 0.24% | 104 |
|
|
2019
Q2 | $1.03M | Buy |
+18,837
| New | +$1.01M | 0.2% | 127 |
|
|
2019
Q1 | – | Sell |
-3,798
| Closed | -$249K | – | 391 |
|
|
2018
Q4 | $249K | Buy |
+3,798
| New | +$284K | 0.06% | 300 |
|
|
2017
Q4 | – | Sell |
-9,200
| Closed | -$748K | – | 315 |
|
|
2017
Q3 | $748K | Sell |
9,200
-2,070
| -18% | -$164K | 0.3% | 103 |
|
|
2017
Q2 | $907K | Buy |
11,270
+4,713
| +72% | +$372K | 0.41% | 70 |
|
|
2017
Q1 | $515K | Buy |
+6,557
| New | +$523K | 0.22% | 101 |
|
Other funds holding CVS
VCM
VPM
Arete Wealth Advisors's CVS Position: Q1 2026 in Review
Arete Wealth Advisors sold out of CVS Health (CVS) in Q1 2026, closing a stake of 9,636 shares — an estimated $765K sold.
Arete Wealth Advisors first reported a position in CVS in Q1 2017 and held it in 28 quarters. The position peaked at $1.85B in Q4 2022. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Arete Wealth Advisors reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
- Arete Wealth Advisors sold 9,636 CVS Health shares in Q1 2026, an estimated $765K.
- Arete Wealth Advisors first reported a position in CVS Health in Q1 2017 and held it in 28 quarters.
- Arete Wealth Advisors's CVS Health position peaked at $1.85B in Q4 2022.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Arete Wealth Advisors's 13F filing for Q1 2026, filed 18 May 2026.